Here, we employ clinical genetic testing cohorts, highly phenotyped definite ARVC cohorts, and population genomic data with and without associated clinical information to describe the genetic architecture of PKP2 cardiomyopathy. This evidence concerns the gene PKP2 and arrhythmogenic right ventricular cardiomyopathy.